
Opinion|Videos|July 13, 2024
ASCO 2024 Highlights: Long-Term Data and the Future of Combination Therapies in Melanoma
Dr Lipson provides insights surrounding combination therapies in melanoma management.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is the value of long-term follow-up data in melanoma? How does this impact use of treatment regimens?
- How do you foresee the role of combination therapies evolving in the treatment of melanoma over the next few years?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
2
Digital Innovation and New Drugs Converge to Transform CRM Care
3
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
4
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
5








































